BIOQUAL, Inc.
BIOQ
$37.51
-$0.19-0.50%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 116.25% | 43.03% | -316.79% | -322.25% | -509.31% |
| Total Depreciation and Amortization | 27.46% | 25.75% | 27.26% | 1.01% | 2.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -248.35% | -86.09% | -86.09% | 899.66% | -57.60% |
| Change in Net Operating Assets | 66.47% | -139.14% | -223.25% | -331.30% | -500.14% |
| Cash from Operations | 133.16% | -38.76% | -68.54% | -92.17% | -76.32% |
| Capital Expenditure | 34.33% | 92.81% | 60.01% | 67.15% | 46.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,082.83% | 92.81% | 60.01% | 67.09% | 46.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.46% | -35.97% | -72.83% | -101.68% | -84.18% |